Video Library

Update on Myeloproliferative Neoplasm (MPNs) by Dr. Ruben Mesa – 2018

Dr. Ruben Mesa, now Director at the UT Health San Antonio. Cancer Center, provides a 2018 update on the treatment of myeloproliferative neoplasms (myelofibrosis, polycythemia vera and essential thrombocythemia. He focuses on the MPN results from the December 2017 meeting of the American Society of Hematology. Follow Dr Mesa on twitter @mpdrc and the UT Health San Antonio Cancer Center @UTHealthCancer.

What is an MPN?

What tests are important for an MPN patient as they go on their journey? MPN Expert, Dr. Srdan Verstovsek, explains.

Drivers or Passengers? Genetics of MDS and MDS/MPN

Diagnosis of MDS or MDS/MPN must begin with morphology (analysis of the form and structure of patient blood or bone marrow cells). When used alone, today’s advanced techniques to study genes and chromosomes don’t give enough information to find out what type of MDS or MDS/MPN a patient has.